According to research report the Optical Imaging Market: Product, Technique, Therapeutic Area, Application, End User – Global Forecast to 2027 forecasts a substantial growth, with the market projected to reach USD 2.9 billion by 2027, up from USD 1.5 billion in 2022, at a remarkable CAGR of 13.5%. Several key factors are driving this market expansion, including an aging population, increased investment in life sciences research and development, rising patient expectations for swift and accurate diagnosis and treatment, greater availability of information and knowledge, and improved healthcare accessibility in Rapidly Developing Economies (RDE).
Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=894
In terms of products, the imaging systems segment is poised to dominate the optical imaging market. The need for high-quality equipment and technologies is driving continuous innovation among market players. Intense competition in the market is pushing for the introduction of improved systems and devices. The demand for non-invasive, radiation-free optical imaging modalities is an additional factor bolstering market growth. Following the imaging systems segment, the camera market is expected to witness increased adoption, driven by its small size, enhanced sensitivity, and high-resolution imaging capabilities for various medical diagnostic applications.
Within the application category, the pathological segment is expected to command the largest share of the optical imaging market. This can be attributed to the high demand for optical imaging systems in diagnosing eye disorders, detecting tumors, cardiovascular diseases, skin lesions, and other medical conditions. Non-invasiveness, precise image capture capabilities, and widespread adoption in clinical practice are fueling the popularity of optical imaging systems for pathological applications.
Hospitals are the leading end users of optical imaging, holding the highest market share. Factors such as increased healthcare funding from both government and private sources, higher adoption of optical imaging in hospitals, access to skilled healthcare professionals and advanced facilities, and a growing overall adoption of optical imaging technologies are contributing to hospitals’ dominance in the optical imaging market. Optical imaging techniques are extensively used in clinics and operating rooms for tumor localization and resection, with fluorescence imaging gaining importance in breast imaging and endoscopy. Furthermore, optical imaging techniques are instrumental in detecting conditions like ovarian cancer, malignant skin lesions, lymphoma, intestinal adenoma, intraoperative scanning, stem cell trafficking, and monitoring patient responses to various treatments.
In terms of regions, North America is expected to maintain its dominance in the optical imaging market during the forecast period. This can be attributed to a surge in glaucoma cases, substantial government support, and significant research and development efforts by well-established companies in the region. Stringent FDA regulations ensure the quality and safety of optical imaging instruments and technologies in North America, encouraging healthcare centers to adopt these technologies and stay up-to-date with advancements.
Request Free Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=894
Prominent players in the optical imaging market include Carl Zeiss Meditec, Abbott, Topcon Corporation, Canon, PerkinElmer, Koninklijke Philips, Heidelberg Engineering, Leica Microsystems, Headwall Photonics, Visionix, Optical Imaging, Optos, Wasatch Photonics, ArcScan, DermaLumics, Cylite, MOPTIM, Michelson Diagnostics, Thorlabs, Hamamatsu Photonics, iTheraMedical, Kibero, Seno Medical, Aspectus Imaging, and Agfa-Gevaert.
Contact:
Mr. Aashish Mehra
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA : 1-888-600-6441
sales@marketsandmarkets.com
